Exel wins Bristol-Myers Squibb's 3PL services contract
Logistics provider will purchase BMS’ Mount Vernon, IN facility and build additional capacity in PA
BMS has chosen Exel (Westerville, OH), the wholly owned contract-logistics subsidiary of DHL, to operate its Mount Vernon, IN distribution center. Exel will purchase and operate the DC, and will open a second DC on its Mechanicsburg, PA campus expressly for BMS. The Exel services include warehousing and distribution of products (both cold-chain and room temperature), clinical trials, samples and exports. BMS will be the primary customer at the facilities, although Exel has the flexibility to add other Exel customers in the future to create a shared-use facility. No financials or contract duration were announced.
Exel has 13 hubs in North America and one in Brazil; of these 14, 4 are specifically designated for life sciences services. Within Exel’s range of operations, there is the capability to perform secondary packaging and kitting, as well as basic storage, distribution and transportation management.
The BMS-Exel deal is similar, in broad outline, to that of UPS, which took over the DCs of Merck in 2009. There, too, the 3PL acquired the facility, and has plans to bring other life sciences clients in to bring efficiencies of scale to overall supply chain services. More such arrangements can be expected as Big Pharma continues to shed non-core assets.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
